Role of Cardiac Biomarkers in Cancer Patients
In patients with cancer—and especially some specific subtypes—the heart can be pathologically affected due to the direct action of the tumor or its secretion products or due to the toxicity of some oncological treatments. Cardiac biomarkers have been investigated as inexpensive and easily accessible...
Guardado en:
Autores principales: | Gennaro Carmine Semeraro, Carlo Maria Cipolla, Daniela Maria Cardinale |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/490324f329744bee9111f56a5418de51 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Trabectedin-Related Heart Failure: Case Report and a Systematic Review of the Literature
por: Julien Catherine, et al.
Publicado: (2021) -
Amiloidosis cardíaca: a propósito de un caso
por: Antileo,Pablo, et al.
Publicado: (2015) -
Association between Helicobacter pylori infection and mortality risk in prostate cancer patients receiving androgen deprivation therapy: A real‐world evidence study
por: Jui‐Ming Liu, et al.
Publicado: (2021) -
Advances in Biomarkers for Detecting Early Cancer Treatment-Related Cardiac Dysfunction
por: Huiyu Xiao, et al.
Publicado: (2021) -
Assesment of the TEI index of myocardial performance in dogs with doxorubicin-induced cardiomiopathy
por: Sousa,MG, et al.
Publicado: (2014)